CoChat

Pharmacodynamic effects and pharmacokinetics of a new HMG‐CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers

Open access
Martin, Paul D., Mitchell, Patrick D., Schneck, Dennis W. · 2002 · British Journal of Clinical Pharmacology
Cited by 148

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Aims To compare the lipid‐regulating effects and steady‐state pharmacokinetics of rosuvastatin, a new synthetic hydroxy methylglutaryl‐coenzyme A (HMG‐CoA) reductase inhibitor, following repeated morning and evening administration in volunteers with fasting serum low‐density lipoprotein cholesterol (LDL‐C) concentrations < 4.14 mmol l−1. Methods In this open‐label two‐way crossover trial 24 healthy adult volunteers were randomized to receive rosuvastatin 10 mg orally each morning (07.00 h) or evening (18.00 h) for 14 days. After a 4 week washout period, volunteers received the alternative regimen for 14 days. Rosuvastatin was administered in the absence of food. Results Reductions from baseline in serum concentrations of LDL‐C (−41.3%[morning]vs−44.2%[evening]), total cholesterol (−30.9%vs−31.8%), triglycerides (−17.1%vs−22.7%), and apolipoprotein B (−32.4%vs−35.3%) were similar following morning and evening administration. AUC(0,24 h) for plasma mevalonic acid (MVA), an in vivo marker of HMG‐CoA reductase activity, decreased by −29.9% (morning) vs−32.6% (evening). Urinary excretion of MVA declined by −33.6% (morning) vs−29.2% (evening). The steady‐state pharmacokinetics of rosuvastatin were very similar following the morning and evening dosing regimens. The Cmax values were 4.58 vs 4.54 ng ml−1, and AUC(0,24 h) values were 40.1 vs 42.7 ng ml−1 h, following morning and evening administration, respectively. There were no serious adverse events during the trial, and rosuvastatin was well tolerated after morning and evening administration. Conclusions The pharmacodynamic effects and pharmacokinetics of rosuvastatin are not dependent on time of dosing. Morning or evening administration is equally effective in lowering LDL‐C.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2125.2002.01688.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 148

Metadata

Authors
Martin, P. D., Mitchell, P. D., & Schneck, D. W.
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
2002-11
Volume
54
Issue
5
Pages
472-477
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W1519606611
Cited by
148
References
2
FWCI
6.96
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacodynamic effects and pharmacokinetics of a new HMG‐CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers. https://app.cochat.ai/papers/10.1046/j.1365-2125.2002.01688.x
The paper
Martin, P. D., Mitchell, P. D., & Schneck, D. W. (2002). Pharmacodynamic effects and pharmacokinetics of a new HMG‐CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers. British Journal of Clinical Pharmacology. https://doi.org/10.1046/j.1365-2125.2002.01688.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.